Eng62, I’m not able to reply privately to your messages.
Let me just say this in all due respect, I am well aware of the low percentage of companies that are able to successfully navigate the FDA gauntlet. I understand the risk and the fact that great science can be flushed if management is incompetent. Nader is not my first choice and I have voiced my concern however the BOD has elected to keep him as the CEO. I know many of these people and major shareholders that are close to the story and I’ll leave it at that.
I know you have been around the biotech block more than once and are calling it the way you see it. It may appear that Nader is going to drive this drug into a ditch despite its impressive safety and efficacy and potential cancer play. There is more than you may be aware of with the CYDY story and I have reasons for staying the course and am very comfortable with my investment.
I am not going to spend my time debating and convincing you that you are wrong and I’m right. I don’t play the stock market much less the OTC. This is a calculated investment and I’m willing to risk my 550k shares because I believe it’s a winner substantially North of the current SP. I’m also willing to take the risk because it’s not going to change my life if I’m wrong.
There are no guarantees and a helluva a lot of risk with biotech start ups however IMO we are on a strong trajectory with many short term catalysts to drive the SP. If the science heads south or Nader spins his wheels and can’t get it done I’ll consider moving on. At this moment we are nowhere near the fire sale you and your fellow shorts are trying to sell.
The only thing I don’t respect is the manner in which you folks go about your business. If you believe what you believe post your opinions with respect. Calling this company a junk company that is a scam and that we are in bed with criminals is just pure BS. It’s the surface story to inspire doubt and fear. That’s your game and something I don’t respect but I know that’s the way the ball rolls.